The $528 Billion Opportunity to Get the Medications Right

Join the Bipartisan Policy Center and GTMRx Institute on February 6

Suboptimal use of medications—prescription drugs that make people sicker, are wrong or are not taken as intended—costs 275,000 lives and adds $528 billion across the health care system each year. As concerns about prescription drug costs dominate the national health care debate, real-world evidence points to a solution: Enhance health and drive down costs through coordinated, team-based, patient-centered care models that leverage technology and diagnostics breakthroughs and engage medication experts.

“Fixing the current trial-and-error approach to medication use is probably the single largest and most achievable thing we can do to improve health, lower costs and enable each member of the care team to focus on what they do best,” said Katherine H. Capps, co-founder and executive director of GTMRx (@GTMRxInstitute). “With more than 10,000 medications available on the market, we simply can’t continue to provide care the way that we have been. The time has come to scale what we know works to get the medications right.”

The GTMRx Institute (GTMRx) and Bipartisan Policy Center (@BPC_Bipartisan) co-hosted event will shine a spotlight on the real and immediate opportunity and showcase proven strategies at work today across health care settings. The call to action is for health care stakeholders to optimize medication use as a way to save lives and save money.

The Commonwealth Fund’s Elizabeth Fowler and Gregory Downing of Innovation Horizons and Health Datapalooza, will keynote the livestreamed public event taking place at the Bipartisan Policy Center Feb. 6, 2020, from 8:30-10:30 a.m. After the public event, leaders from academia, industry, government and care delivery will roll up their sleeves to develop a blueprint for change that GTMRx, with its 750 members, leaders and other partner organizations across the public and private sector, will implement to fundamentally shift the nation’s approach to medication use.

In addition to remarks by Fowler and Downing, Susan Dentzer, senior policy fellow at the Duke-Margolis Center for Health Policy, will moderate a discussion with a panel of leaders whose organizations are among the first movers to implement a personalized, comprehensive, team-based approach to medication management: the Veterans Health Administration’s Carolyn Clancy, MD, deputy under secretary for discovery, education and affiliate networks; Michael Evans, RPh, vice president for enterprise pharmacy and chief pharmacy officer for Geisinger; and Daniel Rehrauer, PharmD, senior manager, medication therapy management program at HealthPartners.

Learn more or register for the GTMRx-Bipartisan Policy Center event. To learn more about the GTMRx Institute or to become an executive member, contact us at